Zhang Lab

University of Michigan

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Prostaglandin D2 receptor
Species	Homo sapiens (Human)
Gene	PTGDR
Synonym	PGD2 receptor DP1 DP1 receptor PTGDR1 prostanoid DP receptor-like Prostanoid DP receptor prostaglandin D2 receptor (DP) PGD receptor [ Show all ]
Disease	Pain Dyslipidaemias Rhinitis Thromboembolism Thrombosis Atopic dermatitis Asthma Allergy Allergic rhinitis [ Show all ]
Length	359
Amino acid sequence	MKSPFYRCQNTTSVEKGNSAVMGGVLFSTGLLGNLLALGLLARSGLGWCSRRPLRPLPSVFYMLVCGLTVTDLLGKCLLSPVVLAAYAQNRSLRVLAPALDNSLCQAFAFFMSFFGLSSTLQLLAMALECWLSLGHPFFYRRHITLRLGALVAPVVSAFSLAFCALPFMGFGKFVQYCPGTWCFIQMVHEEGSLSVLGYSVLYSSLMALLVLATVLCNLGAMRNLYAMHRRLQRHPRSCTRDCAEPRADGREASPQPLEELDHLLLLALMTVLFTMCSLPVIYRAYYGAFKDVKEKNRTSEEAEDLRALRFLSVISIVDPWIFIIFRSPVFRIFFHKIFIRPLRYRSRCSNSTNMESSL
UniProt	Q13258
Protein Data Bank	N/A
GPCR-HGmod model	Q13258
3D structure model	This predicted structure model is from GPCR-EXP Q13258.
BioLiP	N/A
Therapeutic Target Database	T68782
ChEMBL	CHEMBL4427
IUPHAR	338
DrugBank	BE0000296

Ligand

Name	alprostadil
Molecular formula	C20H34O5
IUPAC name	7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
Molecular weight	354.487
Hydrogen bond acceptor	5
Hydrogen bond donor	3
XlogP	3.2
Synonyms	RayVa SMR000112594 Sugiran Vasaprostan Prestwick2_001018 Prostaglandin E1 Prostaglandin-E1 50865-30-0 HEI-507 9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid HMS3268I09 AC1NQXHQ l-PGE1 Alprostadil [USAN:USP:INN:BAN:JAN] MLS000758964 Alprox-TD NCGC00016535-01 Befar (TN) BSPBio_001175 (-)-Protaglandin E1 CHEBI:15544 (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate D0I4DQ 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid Edex (TN) SAM001246840 SR-01000597593-5 Tox21_110482 Vitaros (TN) PGE1 Prink (TN) Prostaglandin E1, >=99.0% (TLC) Prostavasin F5TD010360 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid HMS1791K10 AB00514004-06 HMS3715K17 Alista Lipoprost Alprostadil, European Pharmacopoeia (EP) Reference Standard MR 256 BC205461 NCGC00025234-04 BML1-F06 CAS-745-65-3 (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid CPD000112594 (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid DSSTox_CID_2578 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate Prostin VR pediatric (TN) SCHEMBL33317 SR-01000946253-1 U-10136 ZINC3813088 PGE1;Prostaglandin E1 Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)- Prostaglandin E1; PGE1 50-83-9 GMVPRGQOIOIIMI-DWKJAMRDSA-N 745-65-3 HMS2090L08 AB2000131 K274 Alprostadil (JP17/USP/INN) MFCD00077860 Alprostadilum Muse (TN) BDBM50101853 ONO 1608 BRD-K52459643-001-10-2 (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate Caverject Impulse (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l- 11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0) DTXSID9022578 RP17688 SR-01000597593 SYN3025 Viridal Prestwick3_001018 Prostaglandin E1, 98+% Prostaglandine E EINECS 212-017-2 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid HMS1361K10 AB0014134 HMS3402K10 AI3-62116 l-Prostaglandin E1 Alprostadil(Caverject) MLS001424250 AS-16360 NCGC00025234-02 BG0025 BSPBio_001488 (11?,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid (13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid D0N2EF SAM001246845 SR-01000597593-6 U 10136 W-104416 PGE1 Oligomer Promostan Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture Prostin VR FemLife 7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid HMS1989K10 AB00514004-08 HY-B0131 Liprostin Alprostadil, meets USP testing specifications MR-256 BCP01740 NCGC00025234-05 BPBio1_001293 (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate Caverject (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate CS-1905 11,15-Dihydroxy-9-oxoprost-13-en-1-oate DSSTox_GSID_22578 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid Prostivas SMP2_000271 ST50826271 UNII-F5TD010360 PGE1alpha Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer Prostaglandin E1;Edex;Muse;Liprostin;Caverject GTPL1882 745P653 HMS2098K17 AC-6095 l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid Alprostadil Prostoglandin E1 Minprog Alprostadilum [INN-Latin] NC00438 Befar BRD-K52459643-001-17-7 (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid CCG-101188 (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid D00180 119314-69-1 Edex s1508 SR-01000597593-1 Topiglan Vitaros PGE-1 Prink Prostaglandin E1, >=98% (HPLC), synthetic Prostandin EX-A1411 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid HMS1571K17 AB00514004 HMS3648O17 AKOS015961103 Lipo-alprostadil Alprostadil(usan) MolPort-003-939-183 B2154 NCGC00025234-03 BIDD:GT0747 C04741 (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid CHEMBL495 (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid 22299-37-2 SAM001247093 SR-01000946253 U-10,136 XPG PGE1, Prostaglandin E1, powder Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)- Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture Prostin VR Pediatric 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid Femprox 7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid HMS2052L11 AB00514004_09 IDI1_033958 Alprostadil (JP15/USP/INN) LMFA03010134 Alprostadil, United States Pharmacopeia (USP) Reference Standard Muse BCP9000277 NSC 165559 BRD-K52459643-001-06-0 (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid Caverject (TN) (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)- 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid DSSTox_RID_76640 [ Show all ]
Inchi Key	GMVPRGQOIOIIMI-DWKJAMRDSA-N
Inchi ID	InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1
PubChem CID	5280723
ChEMBL	CHEMBL495
IUPHAR	1882
BindingDB	50101853
DrugBank	DB00770
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Ki	50.1187 nM	PMID9579725	IUPHAR

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218